🇺🇸 FDA
Patent

US 7244558

Production of novel Newcastle disease virus strains from cDNAs and improved live attenuated Newcastle disease vaccines

granted A61KA61K2039/5254A61K39/00

Quick answer

US patent 7244558 (Production of novel Newcastle disease virus strains from cDNAs and improved live attenuated Newcastle disease vaccines) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/5254, A61K39/00, A61K39/12, A61K39/17